Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “pH”

1,259 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,259 results

Early research (Phase 1)Study completedNCT06170723
What this trial is testing

Assess the Effects of Itraconazole, Food, and pH on the Drug Levels of BMS-986368 in Healthy Participants

Who this might be right for
Healthy Participants
Celgene 32
Early research (Phase 1)Study completedNCT01153659
What this trial is testing

Evaluate the Effect on 24-hour, Intragastric pH of RAB ER 50-mg Capsules Compared With Esomeprazole (Nexium) 40 mg Capsules and Rabeprazole (Aciphex) 20-mg Tablets

Who this might be right for
Healthy
Eisai Inc. 90
Not applicableStudy completedNCT02318862
What this trial is testing

Assessment of Esophageal Epithelium Integrity With Mucosal Impedance

Who this might be right for
Gastroesophageal Reflux Disease (GERD)Non-erosive Reflux Disease (NERD)
Vanderbilt University Medical Center 15
Early research (Phase 1)Active Not RecruitingNCT03233854
What this trial is testing

CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies

Who this might be right for
B Acute Lymphoblastic LeukemiaCD19 PositiveMinimal Residual Disease+1 more
Stanford University 56
Early research (Phase 1)Ended earlyNCT04679194
What this trial is testing

Study of Mana 312 (Multi Tumor-Associated Antigen T Cells) in Adults With AML/MDS After HSCT

Who this might be right for
AML/MDS
Mana Therapeutics 11
Not applicableActive Not RecruitingNCT00260572
What this trial is testing

Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease

Who this might be right for
Gastroesophageal Reflux Disease
University of Pittsburgh 2,500
Not applicableStudy completedNCT02118883
What this trial is testing

Dehydration, Rehydration, and Blood Viscosity

Who this might be right for
Dehydration
Essentia Water, LLC 100
Early research (Phase 1)Study completedNCT01665183
What this trial is testing

Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma

Who this might be right for
Cutaneous Melanoma, Uveal Melanoma, Ovarian Carcinoma or Other Advanced Solid Tumors
Polaris Group 8
Not applicableUnknownNCT01561729
What this trial is testing

Nasogastric/Orogastric Tube Placement Verification Study Using RightSpot pH Indicator to Verify Gastric Acidity

Who this might be right for
Small Bowel ObstructionGastrointestinal Hemorrhage
RightBio Metrics 30
Not applicableNot Yet RecruitingNCT07443592
What this trial is testing

Treatment for Ph-negative ALL for Adults up to 65 Years

Who this might be right for
Acute Lymphoblastic Leukemia
PETHEMA Foundation 330
Testing effectiveness (Phase 2)Active Not RecruitingNCT03647163
What this trial is testing

Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid Tumors

Who this might be right for
Solid TumorNon Small Cell Lung CancerNeuroendocrine Carcinoma+1 more
Vyriad, Inc. 33
Post-approval studies (Phase 4)Study completedNCT00171899
What this trial is testing

Study Comparing Standard Dose and High-dose Imatinib Mesylate in Patients With Chronic Phase Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML)

Who this might be right for
Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 80
Large-scale testing (Phase 3)Looking for participantsNCT07234032
What this trial is testing

An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Who this might be right for
Pulmonary HypertensionInterstitial Lung Disease
Insmed Incorporated 344
Not applicableUnknownNCT01533701
What this trial is testing

Scalp Sampling for Fetal Surveillance

Who this might be right for
Fetal Hypoxia
Uppsala University Hospital 60
Early research (Phase 1)WithdrawnNCT00963365
What this trial is testing

AZD6765 Oral Single Ascending Dose/Multiple Ascending Dose (SAD/MAD)

Who this might be right for
Healthy
AstraZeneca
Not applicableLooking for participantsNCT07684131
What this trial is testing

EWALL-PH OBSERVARTORY 2022

Who this might be right for
Acute Lymphoblastic Leukemia
Versailles Hospital 100
Testing effectiveness (Phase 2)Enrolling By InvitationNCT04738422
What this trial is testing

Determining Airway pH by Compartmental Exhaled Nitric Oxide Levels During Alkaline Buffer Challenge

Who this might be right for
Airway Disease
Indiana University 150
Early research (Phase 1)Study completedNCT00351975
What this trial is testing

Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases

Who this might be right for
Accelerated Phase of DiseaseAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+17 more
National Cancer Institute (NCI) 56
Testing effectiveness (Phase 2)Study completedNCT00006475
What this trial is testing

STI571 in Treating Patients With Chronic Myelogenous Leukemia in Blast Crisis

Who this might be right for
Leukemia
Novartis
Testing effectiveness (Phase 2)Ended earlyNCT00923247
What this trial is testing

A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC)

Who this might be right for
Medullary Thyroid Carcinoma
National Cancer Institute (NCI) 22
Next Page